 - Concurrent anticancer treatment or concurrent systemic therapy with steroids or other immunosuppressive agents, or use of any investigational drug within 30 days before the start of trial treatment. Short-term administration of steroids that is, for allergic reactions or the management of immune-related adverse events irAE is allowed 